Canada markets closed

NOXXON Pharma N.V. (ALNOX.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
0.1200+0.0480 (+66.67%)
At close: 05:37PM CEST
Full screen
Loading interactive chart...
  • Business Wire

    NOXXON Announces Presentation of NOX-A12 Phase 1/2 Data in Glioblastoma at The 2022 ASCO Annual Meeting and Invitation to a Dedicated KOL Event

    BERLIN, May 26, 2022--Regulatory News: NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announces publication of the abstract of its poster presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting which will take place in Chicago, Illinois, US, from June 3 to June 7, 2022.

  • Business Wire

    NOXXON Amends Equity-Linked Facility With Atlas

    BERLIN, May 19, 2022--Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today the third amendment to its agreement with Atlas Special Opportunities, LLC (ASO) which increases and equilibrizes all remaining tranches to €1.08 million, adjusts the conversion conditions to those in the original agreement of April 2020 and allows NOXXON to draw two tr

  • Business Wire

    NOXXON Announces Results of the Extraordinary General Meeting of Shareholders

    BERLIN, May 16, 2022--Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that the extraordinary general meeting of shareholders held on Monday, May 16, 2022 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands approved the proposed share consolidation to be implemented by way of parti